171 related articles for article (PubMed ID: 16368269)
1. Glutamate-based therapeutic approaches: targeting the glutamate transport system.
Dunlop J
Curr Opin Pharmacol; 2006 Feb; 6(1):103-7. PubMed ID: 16368269
[TBL] [Abstract][Full Text] [Related]
2. WAY-855 (3-amino-tricyclo[2.2.1.02.6]heptane-1,3-dicarboxylic acid): a novel, EAAT2-preferring, nonsubstrate inhibitor of high-affinity glutamate uptake.
Dunlop J; Eliasof S; Stack G; McIlvain HB; Greenfield A; Kowal D; Petroski R; Carrick T
Br J Pharmacol; 2003 Nov; 140(5):839-46. PubMed ID: 14517179
[TBL] [Abstract][Full Text] [Related]
3. Role of the GLT-1 subtype of glutamate transporter in glutamate homeostasis: the GLT-1-preferring inhibitor WAY-855 produces marginal neurotoxicity in the rat hippocampus.
Selkirk JV; Nottebaum LM; Vana AM; Verge GM; Mackay KB; Stiefel TH; Naeve GS; Pomeroy JE; Petroski RE; Moyer J; Dunlop J; Foster AC
Eur J Neurosci; 2005 Jun; 21(12):3217-28. PubMed ID: 16026460
[TBL] [Abstract][Full Text] [Related]
4. The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes.
Bridges RJ; Esslinger CS
Pharmacol Ther; 2005 Sep; 107(3):271-85. PubMed ID: 16112332
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the tritium-labeled analog of L-threo-beta-benzyloxyaspartate binding to glutamate transporters.
Shimamoto K; Otsubo Y; Shigeri Y; Yasuda-Kamatani Y; Satoh M; Kaneko S; Nakagawa T
Mol Pharmacol; 2007 Jan; 71(1):294-302. PubMed ID: 17047096
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of the human EAAT2 glutamate transporter within neurons of mouse organotypic hippocampal slice cultures leads to increased vulnerability of CA1 pyramidal cells.
Selkirk JV; Stiefel TH; Stone IM; Naeve GS; Foster AC; Poulsen DJ
Eur J Neurosci; 2005 Apr; 21(8):2291-6. PubMed ID: 15869527
[TBL] [Abstract][Full Text] [Related]
7. Excitatory amino acid transporter expression by astrocytes is neuroprotective against microglial excitotoxicity.
Liang J; Takeuchi H; Doi Y; Kawanokuchi J; Sonobe Y; Jin S; Yawata I; Li H; Yasuoka S; Mizuno T; Suzumura A
Brain Res; 2008 May; 1210():11-9. PubMed ID: 18410911
[TBL] [Abstract][Full Text] [Related]
8. Astrocytes: Glutamate transport and alternate splicing of transporters.
Lee A; Pow DV
Int J Biochem Cell Biol; 2010 Dec; 42(12):1901-6. PubMed ID: 20883814
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of glutamate release elicited in rat cerebrocortical nerve endings by 'pathologically' elevated extraterminal K+ concentrations.
Raiteri L; Zappettini S; Milanese M; Fedele E; Raiteri M; Bonanno G
J Neurochem; 2007 Nov; 103(3):952-61. PubMed ID: 17662048
[TBL] [Abstract][Full Text] [Related]
10. Chemo-enzymatic synthesis of (2S,4R)-2-amino-4-(3-(2,2-diphenylethylamino)-3-oxopropyl)pentanedioic acid: a novel selective inhibitor of human excitatory amino acid transporter subtype 2.
Sagot E; Jensen AA; Pickering DS; Pu X; Umberti M; Stensbøl TB; Nielsen B; Assaf Z; Aboab B; Bolte J; Gefflaut T; Bunch L
J Med Chem; 2008 Jul; 51(14):4085-92. PubMed ID: 18578477
[TBL] [Abstract][Full Text] [Related]
11. Expression of PACAP and glutamate transporter proteins in satellite oligodendrocytes of the human CNS.
van Landeghem FK; Weiss T; von Deimling A
Regul Pept; 2007 Jul; 142(1-2):52-9. PubMed ID: 17346813
[TBL] [Abstract][Full Text] [Related]
12. Molecular pharmacology of glutamate transporters, EAATs and VGLUTs.
Shigeri Y; Seal RP; Shimamoto K
Brain Res Brain Res Rev; 2004 Jul; 45(3):250-65. PubMed ID: 15210307
[TBL] [Abstract][Full Text] [Related]
13. Glutamate transporter blockers for elucidation of the function of excitatory neurotransmission systems.
Shimamoto K
Chem Rec; 2008; 8(3):182-99. PubMed ID: 18563834
[TBL] [Abstract][Full Text] [Related]
14. Parawixin1: a spider toxin opening new avenues for glutamate transporter pharmacology.
Torres-Salazar D; Fahlke C
Mol Pharmacol; 2007 Nov; 72(5):1100-2. PubMed ID: 17726155
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay.
Jensen AA; Bräuner-Osborne H
Biochem Pharmacol; 2004 Jun; 67(11):2115-27. PubMed ID: 15135308
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of glutamate transport modulate distinct patterns in brain metabolism.
Moussa CE; Rae C; Bubb WA; Griffin JL; Deters NA; Balcar VJ
J Neurosci Res; 2007 Feb; 85(2):342-50. PubMed ID: 17086545
[TBL] [Abstract][Full Text] [Related]
17. Comparison of [(3)H]-(2S,4R)-4-methylglutamate and [(3)H]D-aspartate as ligands for binding and autoradiographic analyses of glutamate transporters.
Apricò K; Beart PM; Crawford D; O'shea RD
Neurochem Int; 2007 Dec; 51(8):507-16. PubMed ID: 17590480
[TBL] [Abstract][Full Text] [Related]
18. Mercuric chloride inhibits the in vitro uptake of glutamate in GLAST- and GLT-1-transfected mutant CHO-K1 cells.
Mutkus L; Aschner JL; Syversen T; Shanker G; Sonnewald U; Aschner M
Biol Trace Elem Res; 2006 Mar; 109(3):267-80. PubMed ID: 16632895
[TBL] [Abstract][Full Text] [Related]
19. Acute regulation of sodium-dependent glutamate transporters: a focus on constitutive and regulated trafficking.
Robinson MB
Handb Exp Pharmacol; 2006; (175):251-75. PubMed ID: 16722240
[TBL] [Abstract][Full Text] [Related]
20. GLT-1 transporter: an effective pharmacological target for various neurological disorders.
Soni N; Reddy BV; Kumar P
Pharmacol Biochem Behav; 2014 Dec; 127():70-81. PubMed ID: 25312503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
